Tag

Telehealth

All articles tagged with #telehealth

Megan Fox Stars in Bold Ro Sparks Ad, Asks Creators to Tone Down Innuendos
entertainment9 days ago

Megan Fox Stars in Bold Ro Sparks Ad, Asks Creators to Tone Down Innuendos

Megan Fox has signed a long-term deal with telehealth company Ro to star in a new campaign for its erectile dysfunction medication, Ro Sparks. In the ads, Fox wears a red suit and personifies the drug, using humor and double entendres to destigmatize the condition. Fox told People that the original script was so bold she asked the team to dial it back. Ro argues that featuring a woman helps normalize the topic, as ED affects couples. The compounded treatment, which combines sildenafil and tadalafil, is not FDA-approved.

Megan Fox Stars as 'Ro Sparks' in Bold Campaign to Normalize Erectile Dysfunction
advertising12 days ago

Megan Fox Stars as 'Ro Sparks' in Bold Campaign to Normalize Erectile Dysfunction

Megan Fox has signed a long-term deal with telehealth company Ro to star in a new ad campaign for its erectile dysfunction medication, Ro Sparks. The campaign features Fox in a superhero-style red suit, using humor and double entendres to destigmatize the condition. Ro aims to shift the conversation from male-only to a couple-centric approach, arguing that women’s involvement helps break the taboo. The ads will air on linear TV and streaming platforms, with innovative outdoor concepts planned for New York and Los Angeles.

Iowa’s $15.9M Cancer Initiative Distributes 10,000 Radon Kits to Rural Counties
health19 days ago

Iowa’s $15.9M Cancer Initiative Distributes 10,000 Radon Kits to Rural Counties

Iowa has launched a $15.9 million cancer prevention initiative in rural areas, distributing nearly 10,000 free radon test kits and expanding telehealth access. The program, funded by a $209 million federal award, aims to address the state's high cancer rates by improving early detection, training specialists, and providing financial assistance for home mitigation systems.

The Complex Case Behind America’s Rising Antidepressant Use
health1 month ago

The Complex Case Behind America’s Rising Antidepressant Use

Since the pandemic, anxiety and depression have risen and antidepressant prescriptions have surged, with about one in six American adults taking them and SSRIs making up the majority. The piece argues the trend is nuanced: some overuse is possible, but expanded access to mental health care—especially through primary care and telehealth—has also helped people in need. Prescribing is mainly done in primary care, and stopping antidepressants can be difficult for some, though gradual tapering under medical supervision is often possible. Systemic barriers mean many with serious depression still receive limited treatment, underscoring the need to balance medication with nonpharmacological options and broader access to care.

Legal battles intensify over telehealth abortion-pill access
politics1 month ago

Legal battles intensify over telehealth abortion-pill access

States and conservative groups are suing to overturn FDA rules that allow mifepristone via telehealth, arguing such access clashes with bans in many states. Federal cases involving Louisiana, Texas and others are pressing the FDA as courts weigh whether prescribing rules are too restrictive, with a status update deadline of Oct. 7 in some matters. Even if limits tighten, abortion pills could still be accessible through alternatives like misoprostol, sparking debates about state control vs. federal oversight and the future of telehealth for this medication.

politics1 month ago

Louisiana suit could erase online abortion-pill access nationwide

Louisiana is asking the 5th Circuit to overturn FDA rules that allow telehealth prescribing and mail delivery of mifepristone, arguing they undermine its abortion ban. If the suit or similar actions by other states prevail, online and mailed abortion pills could be blocked nationwide, eroding access in states where abortion remains legal and forcing reliance on clinics. Advocates warn this would strain healthcare systems, raise costs, and worsen delays, especially for rural residents, while opponents say it tramples state sovereignty and existing protections for access.

The Perimenopause Startup Boom: Telehealth, Hormones, and a New Health Frontier
technology1 month ago

The Perimenopause Startup Boom: Telehealth, Hormones, and a New Health Frontier

WIRED examines a rapid, venture-backed surge in hormone therapy for perimenopause driven by telehealth platforms (Midi, Winona, Alloy, Evernow) and policy shifts after FDA warnings were lifted, fueling broad marketing of a wide range of symptoms as solvable by hormones. The piece juxtaposes patient‑level relief with warnings about overdiagnosis, safety risks, and supply constraints, arguing the trend reflects a broader move toward platform‑based, privatized women’s health care.

Telehealth scrutiny and mental health debates unfold in Clancy trial
crime2 months ago

Telehealth scrutiny and mental health debates unfold in Clancy trial

Live updates show medical providers, including Dr. Jennifer Tufts, being cross-examined as Lindsay Clancy’s murder trial focuses on whether telehealth and treatment decisions influenced her deteriorating mental health; prosecutors allege a systemic failure to diagnose and treat her condition, while the defense argues postpartum psychosis and overmedication played a role in the killings.

Telehealth-Only Therapy in Clancy Case: Psychiatrist Never Met Patient in Person
crime2 months ago

Telehealth-Only Therapy in Clancy Case: Psychiatrist Never Met Patient in Person

In the Lindsay Clancy murder case, her psychiatrist testified that all sessions with Clancy were conducted via telehealth and she had never met her in person, limiting her ability to observe physical cues (hands/legs). The defense questioned potential misrepresentation of postpartum specialization and whether hospital records were reviewed, noting Clancy’s claims of worsening symptoms and prior hospital visits. The psychiatrist disputed malpractice allegations, saying sessions lasted 25–30 minutes and she provided support, though she did not review hospital records and did not see signs of psychosis in clinic notes.

Chrissy Metz’s GLP-1 Journey: From Skepticism to Cravings Relief and Stamina Boost
health2 months ago

Chrissy Metz’s GLP-1 Journey: From Skepticism to Cravings Relief and Stamina Boost

Chrissy Metz reveals she’s started a GLP-1 medication through Ro after initial skepticism. She says the therapy has quieted her food thoughts, boosted stamina for eight shows a week on Broadway, and even improved inflammation and joint comfort, with her menstrual cycle regulating and body measurements changing enough to require costume tweaks. Metz stresses it isn’t a magic fix, urges careful research and doctor consultation, and notes she expects scrutiny while pursuing long‑term health, including considerations around perimenopause.

Epic’s Leadership Shake-Up Sparks Discussion of a Health-Tech Exodus
health-tech2 months ago

Epic’s Leadership Shake-Up Sparks Discussion of a Health-Tech Exodus

STAT reports a leadership exodus at Epic, highlighted by Sumit Rana’s departure and other executive exits, fueling questions about the company’s direction amid health-tech talent churn; the issue also covers LifeMD’s GLP-1 telehealth controversy, Nabla naming a new CEO as AI competition intensifies, notable hires across Aledade and TytoCare, and a broader health-tech funding and policy roundup.

Telehealth GLP-1 Dose Errors Prompt Hospitalization
health2 months ago

Telehealth GLP-1 Dose Errors Prompt Hospitalization

A NBC News and KFF Health News investigation finds safety gaps in telehealth prescribing of GLP-1 weight-loss drugs, highlighted by a North Carolina woman who was hospitalized after an overdose from dosing instructions she received online. With about 11% of U.S. adults using GLP-1s and a 1,500% increase in overdose/side-effect calls to poison centers from 2019–2025, experts warn that telehealth can lack critical oversight and proper dosing checks, particularly with compounded drugs not reviewed by the FDA. Advocates urge stronger provider access, clearer dosing protocols, and safer sourcing to protect patients.

Secret shoppers reveal minimal medical oversight for online GLP-1 weight-loss scripts
health3 months ago

Secret shoppers reveal minimal medical oversight for online GLP-1 weight-loss scripts

A Yale secret-shopping study in which a Yale medical student posed as a 237-pound patient found that most online GLP-1 weight-loss drug vendors provide lax clinical oversight; only 13 of 49 sites required video consultations, with many relying on unverified online questionnaires, raising patient-safety concerns amid the GLP-1 drug boom.

Surge in GLP-1 overdoses linked to easy telehealth and unregulated meds
health3 months ago

Surge in GLP-1 overdoses linked to easy telehealth and unregulated meds

GLP-1 diabetes/weight‑loss drugs are seeing a rise in life‑threatening overdoses as use has surged since 2021 and telehealth lowers barriers to access, sometimes bypassing in-person care. Poison‑control calls jumped from about 100 monthly in 2021 to roughly 1,000 by 2025, with patients suffering severe vomiting, dehydration, seizures, and even vomiting blood. Compounded or online‑sourced versions can have inconsistent dosing and less doctor oversight, prompting FDA warnings about unregulated products. Experts urge caution, proper dosing, and urgent care for severe symptoms, noting risks like pancreatitis and hypoglycemia, with children also at risk.